FDA accepts Capricor's Biologics License Application for priority review, advancing deramiocel for DMD cardiomyopathy.
After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback